Wolters, Sharon
Carpay, Johannes A.
Pronk, Marja H.
Zuurbier, Karin W.M.
Driessen, Maurice T.
Lyras, Leonidas
Postma, Maarten J.
Funding for this research was provided by:
Teva Pharmaceuticals (n/a)
Article History
Received: 20 October 2023
Accepted: 29 May 2024
First Online: 24 June 2024
Declarations
:
: Ethics approval was not required as data were derived from previously conducted studies, for which ethical approval had been obtained.
: Not applicable.
: SW is an employee of Asc Academics and a consultant to MH Pronk Health Care Consultancy Foundation. JAC has received payment for advisory boards and lectures from Teva Pharmaceuticals, Lilly, Novartis, Lundbeck, and Pfizer. MP is managing director of MH Pronk Health Care Consultancy Foundation and an external consultant to Teva Netherlands B.V. KWMZ is an employee of Teva Netherlands B.V. MTD is an employee of Teva Pharmaceuticals. LL is a former employee of Teva Pharmaceuticals. MJP is a consultant to Asc Academics.